We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$83.8B
AUM Growth
+$3.39B
Cap. Flow
+$41.1M
Cap. Flow %
0.05%
Top 10 Hldgs %
26.49%
Holding
8,017
New
302
Increased
3,328
Reduced
3,470
Closed
580

Sector Composition

Rank Sector Weight
1 Financials 4.63%
2 Healthcare 4.25%
3 Technology 4.18%
4 Energy 3.42%
5 Communication Services 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMC
7501
Summit Midstream
SMC
$427M
-227
Closed -$116K
NBIS
7502
CALL
Nebius Group N.V.
NBIS
$47.6B
-192,100
Closed -$5.31M
NBIS
7503
Nebius Group N.V.
NBIS
$47.6B
-100,260
Closed -$2.77M
NBIS
7504
PUT
Nebius Group N.V.
NBIS
$47.6B
-31,100
Closed -$860K
EQC
7505
CALL
DELISTED
Equity Commonwealth
EQC
-75,500
Closed -$1.75M
CUTR
7506
CALL
DELISTED
Cutera, Inc.
CUTR
-1,000
Closed -$9K
CDMO
7507
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-10,357
Closed -$94K
AUMN
7508
DELISTED
Golden Minerals Company
AUMN
$0 ﹤0.01%
15
-1,245
-99% -$39.6K
CVLY
7509
DELISTED
Codorus Valley Bancorp Inc
CVLY
-148
Closed -$2K
DLA
7510
DELISTED
Delta Apparel Inc.
DLA
-8,119
Closed -$114K
TARO
7511
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-2,645
Closed -$148K
TGH
7512
DELISTED
Textainer Group Holdings limited
TGH
-643
Closed -$24K
FRTX
7513
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-5
Closed -$46K
ARGO
7514
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-8,186
Closed -$249K
ACER
7515
DELISTED
Acer Therapeutics Inc
ACER
-79
Closed -$10K
PRTK
7516
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-986
Closed -$36K
ATCO
7517
DELISTED
Atlas Corp.
ATCO
-22,824
Closed -$496K
ALBO
7518
DELISTED
Albireo Pharma Inc
ALBO
-3
Closed -$391
DS
7519
CALL
DELISTED
Drive Shack Inc.
DS
-66,453
Closed -$314K
DS
7520
PUT
DELISTED
Drive Shack Inc.
DS
-63,910
Closed -$302K
AATC
7521
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
-100
Closed -$1K
HIL
7522
DELISTED
Hill International, Inc. Common Stock
HIL
-21,365
Closed -$59K
TGA
7523
DELISTED
Transglobe Energy Corp
TGA
-230
Closed -$1.57K
TGA
7524
PUT
DELISTED
Transglobe Energy Corp
TGA
-4,500
Closed -$28K
BBQ
7525
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
-300
Closed -$5K

Similar funds

Barclays's Q3 2013 Portfolio in Review

As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.

  • Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
  • Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
  • Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
  • Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
  • Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
  • Barclays opened 302 new positions and closed 580 in Q3 2013.
  • Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.

Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.